Macquarie Group
GOSS icon

Macquarie Group’s Gossamer Bio GOSS Stock Holding History

Macquarie Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,271
Closed -$11 – 1993
2024
Q1 		$11 Buy
+9,271
New +$10.2K ﹤0.01% 1722
2022
Q4 		– Sell
-556
Closed -$19K – 1909
2022
Q3 		$19K Sell
556
-1,019
-65% -$12.6K ﹤0.01% 2215
2022
Q2 		$13K Hold
1,575
– – ﹤0.01% 2402
2022
Q1 		$14 Hold
1,575
– – ﹤0.01% 2463
2021
Q4 		$18K Hold
1,575
– – ﹤0.01% 2417
2021
Q3 		$20K Hold
1,575
– – ﹤0.01% 2455
2021
Q2 		$13K Hold
1,575
– – ﹤0.01% 2443
2021
Q1 		$15K Sell
1,575
-483
-23% -$4.87K ﹤0.01% 2335
2020
Q4 		$20K Hold
2,058
– – ﹤0.01% 2218
2020
Q3 		$26K Hold
2,058
– – ﹤0.01% 2107
2020
Q2 		$27K Buy
+2,058
New +$25.9K ﹤0.01% 2084

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group's GOSS Position: Q2 2024 in Review

Macquarie Group sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 9,271 shares — an estimated $11 sold.

Macquarie Group first reported a position in GOSS in Q2 2020 and held it in 11 quarters. The position peaked at $27K in Q2 2020. 94 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • Macquarie Group reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 9,271 Gossamer Bio shares in Q2 2024, an estimated $11.
  • Macquarie Group first reported a position in Gossamer Bio in Q2 2020 and held it in 11 quarters.
  • Macquarie Group's Gossamer Bio position peaked at $27K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.